Tachycardia, Ventricular

2
Pipeline Programs
4
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Rhythm Pharmaceuticals
3 programs
2
Implantable Cardiac DefibrillatorPhase 41 trial
Implantable Cardiac DefibrillatorPhase 41 trial
Implanted DeviceN/A1 trial
Active Trials
NCT00279279Completed700Est. May 2006
NCT00147277Completed925Est. Jan 2008
NCT00147290Completed526Est. Jan 2008
Siemens Healthineers
Siemens HealthineersGermany - Forchheim
2 programs
CyberHeart SystemN/A1 trial
Varian Cardiac RadioablationN/A1 trial
Active Trials
NCT02661048CompletedEst. Jul 2023
NCT05765175RecruitingEst. May 2030
Abbott
AbbottABBOTT PARK, IL
1 program
ICD implant + Patient Notifier turned OFFN/A1 trial
Active Trials
NCT00559559Completed362Est. Dec 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Rhythm PharmaceuticalsImplantable Cardiac Defibrillator
Rhythm PharmaceuticalsImplantable Cardiac Defibrillator
Siemens HealthineersVarian Cardiac Radioablation
Siemens HealthineersCyberHeart System
AbbottICD implant + Patient Notifier turned OFF
Rhythm PharmaceuticalsImplanted Device

Clinical Trials (6)

Total enrollment: 2,513 patients across 6 trials

NCT00147277Rhythm PharmaceuticalsImplantable Cardiac Defibrillator

ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy

Start: Mar 2004Est. completion: Jan 2008925 patients
Phase 4Completed
NCT00147290Rhythm PharmaceuticalsImplantable Cardiac Defibrillator

ADVANCE CRT - D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy

Start: Feb 2004Est. completion: Jan 2008526 patients
Phase 4Completed
NCT05765175Siemens HealthineersVarian Cardiac Radioablation

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

Start: Apr 2023Est. completion: May 2030
N/ARecruiting
NCT02661048Siemens HealthineersCyberHeart System

CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients With Refractory Ventricular Tachycardia/Fibrillation

Start: Feb 2015Est. completion: Jul 2023
N/ACompleted
NCT00559559AbbottICD implant + Patient Notifier turned OFF

PAtient NOtifier Feature for Reduction of Anxiety

Start: Dec 2007Est. completion: Dec 2010362 patients
N/ACompleted
NCT00279279Rhythm PharmaceuticalsImplanted Device

PREPARE - Primary Prevention Parameters Evaluation

Start: Oct 2003Est. completion: May 2006700 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 2,513 patients
4 companies competing in this space